Phase I Study of the Anti Insulin-Like Growth Factor 1 Receptor (IGF-1R) Monoclonal Antibody, AVE1642, as Single Agent and in Combination With Bortezomib in Patients With Relapsed Multiple Myeloma

Leukemia - United Kingdom
doi 10.1038/leu.2011.4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC